DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers.
- DOI
- 10.3390/cancers12010054
- Published
- 2019 Dec 23
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers12010054,
title = {DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers.},
author = {Sureban SM and Berahovich R and Zhou H and Xu S and Wu L and Ding K and May R and Qu D and Bannerman-Menson E and Golubovskaya V and Houchen CW},
year = {2019},
journal = {Cancers},
doi = {10.3390/cancers12010054},
url = {https://doi.org/10.3390/cancers12010054}
}RIS
TY - JOUR TI - DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers. AU - Sureban SM AU - Berahovich R AU - Zhou H AU - Xu S AU - Wu L AU - Ding K AU - May R AU - Qu D AU - Bannerman-Menson E AU - Golubovskaya V AU - Houchen CW PY - 2019 JO - Cancers DO - 10.3390/cancers12010054 UR - https://doi.org/10.3390/cancers12010054 ER -
APA
SM, S., R, B., H, Z., S, X., L, W., K, D., R, M., D, Q., E, B., V, G., & CW, H. (2019). DCLK1 Monoclonal Antibody-Based CAR-T Cells as a Novel Treatment Strategy against Human Colorectal Cancers.. Cancers. https://doi.org/10.3390/cancers12010054
Source records
- pubmed · retrieved 2026-09-27T14:33:01.096Z